BIO vs HAL · rev $2.58B vs P/E 9.3, $19.05B cap
BIO (BIO) versus Halliburton Company (HAL) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Latest reported BIO revenue for 2025-12-31 was $2.58B. Net income was $759.9M. Revenue was up 0.7% from 2024-12-31 to 2025-12-31. BIO currently screens at market cap $0.
HAL does not have a complete income-statement cache yet.
BIO currently screens at market cap $0. HAL currently screens at market cap $19.05B and trailing P/E 9.3.
Not investment advice. Open the BIO and HAL stock pages for the full models.
Not investment advice.